Guardant wins nod from FDA for Shield test for colorectal cancer
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
The FDA has given approval to Guardant for its Shield test. The test is intended for use in detecting colorectal cancer. This development marks a regulatory milestone for the company's diagnostic product.